What Is the Prognosis for Patients with EGFR-Mutant Cancers?
The prognosis for patients with EGFR-mutant cancers has improved significantly with the advent of targeted therapies. However, the long-term outlook can vary based on the type of mutation, the effectiveness of the treatment, and the development of resistance. Continuous research and clinical trials are essential to improve outcomes and develop new therapeutic strategies.
